Advertisement

Topics

Latest "South African Chemical Institute" News Stories

22:25 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "South African Chemical Institute" found in our extensive news archives from over 250 global news sources.

More Information about South African Chemical Institute on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about South African Chemical Institute for you to read. Along with our medical data and news we also list South African Chemical Institute Clinical Trials, which are updated daily. BioPortfolio also has a large database of South African Chemical Institute Companies for you to search.

Showing "South African Chemical Institute" News Articles 1–25 of 10,000+

Tuesday 18th December 2018

Interesting stat in IQVIA new #OrphanDrug report ~40% (217/503) orphan drugs no longer protected by either orphan exclusivity or patent designations, but only half (116) of these currently face generic competitors https://www.iqvia.com/institute/report

Interesting stat in IQVIA new #OrphanDrug report ~40% (217/503) orphan drugs no longer protected by either orphan exclusivity or patent designations, but only half (116) of these currently face generic competitors https://www.iqvia.com/institute/reports/orphan-drugs-in-the-united-states-exclusivity-pricing-and-treated-populations?sf96397592=1&sf96397592=1 …


Canadian Cancer Trials Group Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryCanadian Cancer Trials Group CCTG, is a subsidiary of Cancer Research Institute at Queen's University, is a contract research organization that conducts clinical trials. The company conducts trials for the development of new drugs and therapies for the treatment of various diseases. It provides services for cancer therapy, supportive care and prevention. CCTG offers clinical trials for prod...

New RNA sequencing strategy to study gut microbiome activity

Researchers have developed a high-throughput RNA sequencing strategy to study the activity of the gut microbiome. The new tools analyse transfer RNA (tRNA), a molecular Rosetta Stone that translates the genetic information encoded in DNA into proteins that perform basic biological functions. Developing a clear picture of tRNA dynamics will allow scientists to understand the activity of naturally ...


Scientists at @christianacare's Helen F. Graham Cancer Center & Research Institute use #CRISPR to disable the NRF2 gene in lab-grown #lungcancer cells: http://ow.ly/BhVT30n21oW 

Scientists at @christianacare's Helen F. Graham Cancer Center & Research Institute use #CRISPR to disable the NRF2 gene in lab-grown #lungcancer cells: http://ow.ly/BhVT30n21oW 

Alzheimer’s Protein May Be Transmissible, in Rare Cases

A group from the University College London (UCL), Institute of Prion Diseases has put another puzzle piece in place in the case of deaths caused by human cadaveric growth hormone (c-hGH.) Some people who had received the c-hGH as children to help stimulate growth died of Creutzfeldt–Jakob disease (CJD)—transmissible spongiform encephalopathy characterized by progressive and irreversible [R...

ASCO 2018 - Will Taking Mod to High Dose Steroids Affect Lung Cancer Patients on Immunotherapy?

ASCO 2018 RoundtableHoward (Jack) West, MD, Founder and President

ASCO 2018 Roundtable - Checkmate 227 - Combinations of Nivolumab and Ipilimumab, or Nivolumab and and Chemo

ASCO 2018 Roundtable Howard (Jack) West, MD, Founder and President

South Korea Respiratory Device Accessories Market Outlook to 2025 [Report Updated: 03102018] Prices from USD $4246

South Korea Respiratory Device Accessories Market Outlook to 2025SummaryGlobalData's new report, South Korea Respiratory Device Accessories Market Outlook to 2025, provides key market data on the South Korea Respiratory Device Accessories market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Aerosol Masks, CardioPulmonary Resus...

Scynexis Inc SCYX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryScynexis Inc Scynexis is a pharmaceutical company that discovers, develops and commercializes novel antiinfective for various therapeutic needs. The company provides pipeline products such as SCY078, is used for invasive fungal infections; SCY635, is used for the treatment of Hepatitis C HCV; SCYX7158, is used for sleeping sickness; SCY641, is for human health, among others. Its SCY078 is a...

Cyprotex Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 11122018] Prices from USD $250

SummaryCyprotex Ltd Cyprotex, a subsidiary of Evotec AG is a provider of ADMETox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company's core capabilities include high quality mechanistic toxicology, in vitro ADME screening services, and high content toxicology screening services, including propriet...

Health, Beauty And Wellness News: Nutrisystem Adds Options, Roar Gains $5.6M, SynTech Elite In US, More News

Nurtisystem launches FreshStart, South Beach Keto; Roar Beverage $5.6m funding led by AccelFoods; SynTech brings Elite Series to US; ChromaDex...   

Exclusive: Erik Halvorsen out at TMC Innovation Institute. Reports are that he was fired

Last week several publications reported that Erik Halvorsen, director of the Innovation Institute at the Texas Medical Center, has stepped down. Turns out he and another employee were fired.

How accurate are budget impact models at the national level?

That is the question of interest of a new study by Snider et al. (2018) in Value in Health.  The authors use six reviews by the Institute for Clinical and Economic Review (ICER) that forecast the likely national spend on specific drugs or drug classes as case studies.  Their study compares these forecast to subsequent…

QRxPharma Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryQRxPharma Ltd QRxPharma develops and commercializes treatments for pain management and abuse prevention products. The company's product portfolio includes late and early stage clinical drug candidates. Its dual opioid product portfolio includes Moxduo IR Q8003, an immediate release oral capsule for the treatment of acute management of moderate to severe pain; Moxduo IV Q8012, an intravenous...

MRI improves liver fat monitoring in obese patients

For patients who undergo weight loss treatments for obesity, a specialized MRI sequence called quantitative chemical shift encoded MRI (CSE-MRI) may provide a safe and noninvasive way to monitor liver fat levels and the success of treatments, according to new research published online Dec. 18 in Radiology.

Your NEJM Group Today: Hospital Within a Hospital / Avoid SGLT2 Inhibitors in Certain Diabetics? / Florida Family Medicine Opportunities

Take a look at today's highlights from NEJM Group: NEJM Catalyst: Case study: The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers...

U.S. Chemical Production Edged Higher in November

WASHINGTON, Dec. 18, 2018 /PRNewswire/ -- According to the American Chemistry Council (ACC), the U.S. Chemical Production Regional Index (U.S. CPRI) rose by 0.2 percent Read more...

Hondros Education Group Announces Acquisition Of Pennsylvania and New Jersey Real Estate School

PHILADELPHIA, Dec. 18, 2018 /PRNewswire/ -- Hondros Education Group (HEG), proudly announced today that it has acquired Schlicher-Kratz Institute, in a partnership that will advance Read more...

How chemical shift-encoded MRI can help obese patients after weight loss treatments

MRI scans can be used to monitor liver fat levels in obese patients who undergo bariatric surgery, according to new findings published in Radiology.

US FDA clears Bridge Biotherapeutics' IND application for BBT─877 to treat IPF

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS TMC in Houston, Texas, announced that the Investigational New

CRISPR Restores Lung Cancer Sensitivity to Chemotherapy

Scientists in the U.S. have shown how CRISPR-Cas9 gene editing can be used to restore the effectiveness of first-line chemotherapies against lung cancer, by knocking down a tumor gene that acts as a master regulator of genes involved in the development of resistance. Eric B. Kmiec, Ph.D., and colleagues at the Gene Editing Institute of […] The post CRISPR Restores Lung Cancer Sensitivity to ...

California Life Sciences Association (CLSA) Names Mike Guerra President & CEO of CLSA

Guerra to succeed Sara Radcliffe as organization transitions leadership California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, today announced the appointment of Mike Guerra as President and CEO of CLSA effective January 7, 2019. He will succeed Sara Radcliffe, who will be d...

AHN Opens Alexis Joy D'Achille Center, Offering New Hope to Women With Postpartum Depression

The Alexis Joy D'Achille Center for Perinatal Mental Health, at Allegheny Health Network's West Penn Hospital, is one of just a handful of centers in the United States offering a spectrum of treatments for pregnancy-related depression under one roof - all of which allow mother and baby to stay together at all times - as well as child care for older children of moms who are undergoing treat...

Injectable RNA Therapy Dramatically Improves Vision in Child Blindness

A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania. The post Injectable RNA Therapy Dramatically Improves Vision in Child Blindness appeared first on GEN - Genetic Eng...

Key Chemical Component in Medical Marijuana Appears to Raise Eye Pressure

Although one of the most commonly proposed uses of medical marijuana is to treat glaucoma, scientists at Indiana University have found that a major chemical component in the substance appears to worsen the primary underpinning of the disease: a rise in pressure inside the eye. The chemical in question that is cannabidiol, or CBD, a non-psychoactive […] The post Key Chemical Component in Med...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks